Clinical Trial Update: the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigates whether pretreating women with Diane-35 improves in-vitro fertilization outcomes in patients with Polycystic Ovary Syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Diane-35 (ethinylestradiol / cyproterone acetate)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: UNKNOWN